Polymorphisms in cytokines and growth factor genes and their association with acute rejection and recurrence of hepatitis C virus disease in liver transplantation

被引:36
作者
Mas, VR
Fisher, RA
Maluf, DG
Archer, KJ
Contos, MJ
Mills, SA
Shiffman, ML
Wilkinson, DS
Oliveros, L
Garrett, CT
Ferreira-Gonzalez, A
机构
[1] Virginia Commonwealth Univ, Mol Diagnost Lab, Clin Support Ctr, Dept Pathol, Richmond, VA 23298 USA
[2] Natl Univ San Luis, Sch Chem Biochem & Pharm, Dept Biochem & Biol Sci, San Luis, Argentina
[3] Virginia Commonwealth Univ, Dept Surg, Richmond, VA USA
[4] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA
[5] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA
[6] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA
关键词
cytokines; genetic polymorphisms; hepatitis C virus; liver transplantation; single-nucleotide polymorphisms;
D O I
10.1111/j.0009-9163.2004.00208.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Acute rejection (AR) and recurrence of hepatitis C virus (HCV) infection are complications after liver transplantation (LTx). Genetic factors play a role in cytokine production as a consequence of polymorphisms within cytokine genes. Our goal was to identify genetic factors that might be associated with AR and recurrence of HCV in liver transplant recipients (LTxRs). We studied 77 Caucasian LTxRs and 100 Caucasian healthy individuals. We studied single-nucleotide polymorphisms (SNPs) in tumor necrosis factor-alpha [TNF-alpha, interleukin-6 (IL-6), IL-10, transforming growth factor-beta1, and angiotensin-converting enzyme genes by SNaPSHOT(TM) Multiplex assay. SNPs were classified as high producers (HP), intermediate producers (IP), or low producers (LP),. and their association with AR and recurrence of HCV were studied. The frequency of TNF-alpha IP and HP genotypes was significantly higher in LTxRs with AR in comparison to patients without AR (TNF-alpha HP -238: 63 vs 20%, p < 0.001; TNF-alpha HP -308: 47.4 vs 20%, p = 0.02). The frequency of IL-6 IP and HP genotypes was higher in patients with AR episodes, but the difference was not statistically significant (p = 0.14). However, when we analyzed the simultaneous presence of pro-inflammatory genotypes in the same patient. we found a significant difference between patients with and without AR. respectively (42.1 vs 14.6%, p = 0.012). Moreover, the frequency of the IL-10 LP genotype was higher in LTx patients with AR (p = 0.001) compared to patients without AR. There was an association between pro-inflammatory genotypes and HCV recurrence. Our data suggest that cytokine gene polymorphisms might play a role in AR and HCV recurrence in LTxRs.
引用
收藏
页码:191 / 201
页数:11
相关论文
共 30 条
[1]  
Ahmed A, 2001, Clin Liver Dis, V5, P1073, DOI 10.1016/S1089-3261(05)70210-5
[2]   The effect of polymorphisms in tumor necrosis factor-α, interleukin-10, and transforming growth factor-β1 genes in acute hepatic allograft rejection [J].
Bathgate, AJ ;
Pravica, V ;
Perrey, C ;
Theraponods, G ;
Plevris, JN ;
Hayes, PC ;
Hutchinson, IV .
TRANSPLANTATION, 2000, 69 (07) :1514-1517
[3]  
Belli L S, 1996, Liver Transpl Surg, V2, P200, DOI 10.1002/lt.500020305
[4]   The role of interleukin 10 in the regulation of allergic immune responses [J].
Bellinghausen, I ;
Knop, J ;
Saloga, J .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2001, 126 (02) :97-101
[5]   Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease [J].
Bouma, G ;
Crusius, JBA ;
Pool, MO ;
Kolkman, JJ ;
VonBlomberg, BME ;
Kostense, PJ ;
Giphart, MJ ;
Schreuder, GMT ;
Meuwissen, SGM ;
Pena, AS .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 43 (04) :456-463
[6]   Interleukin-6 is a major effector molecule of short-term G-CSF treatment inducing bone metabolism and an acute-phase response [J].
Carstanjen, D ;
Regenfus, M ;
Müller, C ;
Salama, A .
EXPERIMENTAL HEMATOLOGY, 2001, 29 (07) :812-821
[7]   A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation [J].
Fisher, RA ;
Ham, JM ;
Marcos, A ;
Shiffman, ML ;
Luketic, VA ;
Kimball, PM ;
Sanyal, AJ ;
Wolfe, L ;
Chodorov, A ;
Posner, MP .
TRANSPLANTATION, 1998, 66 (12) :1616-1621
[8]   The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis [J].
Fishman, D ;
Faulds, G ;
Jeffery, R ;
Mohamed-Ali, V ;
Yudkin, JS ;
Humphries, S ;
Woo, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1369-1376
[9]   PCR AMPLIFICATION OF DNA FROM STAINED CYTOLOGICAL SMEARS [J].
GALL, K ;
PAVICIC, D ;
PAVELIC, J ;
AUDYJURKOVIC, S ;
PAVELIC, K .
JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (04) :378-379
[10]   Alternatively activated antigen-presenting cells: Molecular repertoire, immune regulation, and healing [J].
Gratchev, A ;
Schledzewski, K ;
Guillot, P ;
Goerdt, S .
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 2001, 14 (05) :272-279